reports
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce...
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin JUPITER, Fla. and ANKENY, Iowa, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life science, food and nutrition, and bio-industrial uses, and Proliant Health & Biologicals (“Proliant”), a leading global producer of albumin and other purified proteins for life science, nutrition, and diagnostic app...
Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial ...
Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser Company expands ISO 13485/MDSAP Certification to support growing wound care portfolio WINNIPEG, Manitoba, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSXV:KNE) (“Kane Biotech”. “Kane” or the “Company”) today announces two regulatory milestones that strengthen the Company’s wound care platform and reinforce its commitment to high quality, evidence-based medical device development. Kane has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its revyve® Antimicrobial S...
SAIC Announces CEO Appointment
SAIC Announces CEO Appointment Interim CEO, Former Board Member, and Seasoned Government Services Executive James Reagan Named CEO RESTON, Va., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corporation (Nasdaq: ), a premier Fortune 500® company driving our nation's digital transformation across the defense, space, civilian, and intelligence markets, today announced that the Company’s Board of Directors has appointed James (“Jim”) Reagan, Chief Executive Officer, effective immediately. “Following a thorough search process, the selection of Jim Reagan as CEO was a ...
CorVel Earns Sixth Consecutive Great Place To Work® Certification™, Re...
CorVel Earns Sixth Consecutive Great Place To Work® Certification™, Reflecting Continued Investment in Employees and Innovation FORT WORTH, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) is proud to be Certified™ by Great Place To Work® for the sixth consecutive year, an honor based entirely on employee feedback regarding their experience working at CorVel. The certification reflects the company’s focus on creating a workplace where employees feel supported, empowered, and equipped to do their best work. This year, employees recognized the company’s forward-lo...
DBGI Announces Extension of Warrant Exercise Period
DBGI Announces Extension of Warrant Exercise Period Austin, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Digital Brands Group, Inc. (“DBG” or the “Company”) (Ticker: [NASDAQ:DBGI]), a publicly traded company specializing in eCommerce and Fashion, today announced that it has entered into letter agreements (the “Agreements”) with certain existing holders (the “Holders”) of Common Share Purchase Warrants (the “Existing Warrants”) previously issued by the Company in an offering pursuant to that certain Registration Statement Form S-1 declared effective on February 11, 2025 (File No.: 333-284508)....
FLSmidth announces intention to initiate a new share buy-back programm...
FLSmidth announces intention to initiate a new share buy-back programme of up to DKK 1.0 billion COMPANY ANNOUNCEMENT NO. 11-2026FLSmidth & Co. A/S17 February 2026Copenhagen, Denmark FLSmidth & Co. A/S (“FLSmidth”) today announces the intention to initiate a new share buy-back programme of up to DKK 1.0 billion after the release of its Q1 2026 financial results. The company’s intention to initiate a share buy-back programme is supported by a solid balance sheet, sound cash-flow generation and the expected net cash proceeds from the sale of the company’s former corporate headquarters to...
Lifecore Biomedical to Participate at DCAT Week 2026
Lifecore Biomedical to Participate at DCAT Week 2026 CHASKA, Minn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at DCAT Week 2026. The conference will take place March 23-26, 2026, in New York City. Details regarding Lifecore’s participation are as follows: DCAT Week 2026Details: Lifecore team will host customers and prospective partners to discuss development and manufacturing solutions for existing and n...
Kraig Biocraft Laboratories Activates First Wave of 2026 Production Pr...
Kraig Biocraft Laboratories Activates First Wave of 2026 Production Program ANN ARBOR, Mich., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that its 2026 production plan has officially moved from strategy to execution. The Company has now moved bio-material to incubation, getting a jumpstart on its March production plan and formally initiating its multi-ton spider silk scale-up initiative. This milestone follows Kraig’s recently announced 2026 produ...
Gilat Receives $9 Million Order for Defense SATCOM Solutions from Isra...
Gilat Receives $9 Million Order for Defense SATCOM Solutions from Israel’s Ministry of Defense Gilat Defense will deliver advanced modems to support and scale secure, mission-critical satellite communications for defense operations PETAH TIKVA, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that its defense division, Gilat Defense, has been awarded a contract valued $9 million by Israel’s Ministry of Defense for the delivery and integration...
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Health...
Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference – Virtual presentation scheduled for Thursday, February 26, 2026, at 4:00 PM ET –– Webcast may be accessed – MIAMI, Feb. 17, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic oral MEK inhibitor for the treatment of NF1-associated plexiform neurofibromas (NF1-PN), today announced that Chief Executive Officer Tiago Reis Marques will present at the Oppenheimer 36th Annual Healthcare...
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences ALACHUA, Fla. and TAMPA, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management is scheduled to participate in three upcoming investor conferences: Raymond James 47th Annual Institutional Investors ConferenceParticipation: Presentation and 1x1 investor meetingsDate/Time: Presentation Tuesday, March 3, 2026, 3:25 PM ETWebcast Link: Leerink Global Heal...
Perspective Therapeutics to Provide Business Highlights and Report Ful...
Perspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results SEATTLE, Feb. 17, 2026 (GLOBE NEWSWIRE) -- ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that it will report its full year 2025 financial results and provide a business update on Monday, March 16, 2025 after the market closes. The press release will be available on the newsroom section of the Company's website at . About Perspective Therapeutics, Inc. Persp...
Can-Fite Announces Scientific Breakthrough Publication Demonstrating A...
Can-Fite Announces Scientific Breakthrough Publication Demonstrating Anti-Obesity Effect of Namodenoson Namodenoson’s Favorable Safety Profile and Broad Patent Portfolio Positions it as a Promising Candidate in the Growing Obesity Treatment Market Ramat Gan, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company advancing a pipeline of proprietary small molecule drugs addressing oncological and inflammatory diseases, today announced the publication of a peer-reviewed study in the International Journal ...
Independent Data Monitoring Committee Recommends Initiation of Cohort ...
Independent Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 12 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study -- Patients in Cohort 1 have progressed to the open label, Phase 2 portion of ELEVATE-44-201 -- -- Company on track to report ELEVATE-44-201 Cohort 1 data in Q2 2026, with Cohort 2 data by end of year -- BOSTON, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that an independent Data Monitoring Committee (DMC), per study protocol, has reviewed all available safety and PK data from the eight pat...
OTC Markets Group Welcomes Goliath Resources Ltd. to OTCQX
OTC Markets Group Welcomes Goliath Resources Ltd. to OTCQX NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (TSX-V: GOT; OTCQX: GOTRF), a precious metals project generator, has qualified to trade on the OTCQX® Best Market. Goliath Resources Ltd. upgraded to OTCQX from the OTCQB® Venture Market. Goliath Resources Ltd. begins trading today on OTCQX under the symbol “GOTRF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . The...
OTC Markets Group Welcomes Ballston Spa Bancorp, Inc. to OTCQX
OTC Markets Group Welcomes Ballston Spa Bancorp, Inc. to OTCQX NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (OTCQX: BSPA), the holding company of Ballston Spa National Bank, has qualified to trade on the OTCQX® Best Market. Ballston Spa Bancorp, Inc. begins trading today on OTCQX under the symbol “BSPA.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . The OTCQX Market serves as a more efficient and cost-effective publi...
OTC Markets Group Welcomes Headwater Gold Inc. to OTCQX
OTC Markets Group Welcomes Headwater Gold Inc. to OTCQX NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced (CSE: HWE; OTCQX: HWAUF), a technically-driven mineral exploration company, has qualified to trade on the OTCQX® Best Market. Headwater Gold Inc. upgraded to OTCQX from the OTCQB® Venture Market. Headwater Gold Inc. begins trading today on OTCQX under the symbol “HWAUF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on . T...
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Applicati...
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting NRx together with Osmind, Inc. conducted an in-person meeting attended by leadership of the FDA Division of Psychiatry Products and leadership of the FDA Center for Drug Evaluation and Research (CDER)Oral guidance received at the meeting provides a path to filing an application for New Drug Approval of NRX-100 under already-awarded Fast Track Designation based on existing clinical trial data and Real World EvidenceB...
Nutriband Signs Exclusive Distribution Agreement with Innomedica for A...
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica ORLANDO, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. today announced that it has signed an exclusive distribution agreement with Costa Rica Based Innomedica for AVERSA Fentanyl upon approval and all sports tape products manufactured at its Pocono Pharmaceutical / Active Intell subsidiary. Innomedica will also be overseeing and financing all regulatory approvals for the above mentioned products as they ramp up for launch. About AVERSA™ Abuse-Deterrent...
AtaiBeckley To Participate in Upcoming Investor Conferences
AtaiBeckley To Participate in Upcoming Investor Conferences NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced that Srinivas Rao, M.D., Ph.D., Co-Founder and Chief Executive Officer, and Jason Awe, Ph.D., Vice President of Investor Relations, will participate in fireside chats and host one-on-one meetings at the following investor conferences in March. TD Cowen ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.